Healthcare (SH:603313)2025-01-24 10:05Financial Performance Expectations - The company expects a net loss attributable to shareholders for 2024 to be between 120 million and 160 million RMB, compared to a profit of 106.6 million RMB in the same period last year [3]. - The expected net loss after deducting non-recurring gains and losses is projected to be between 220 million and 300 million RMB for 2024, compared to a profit of 101.0 million RMB last year [5]. - The company reported a basic earnings per share of 0.22 RMB in the previous year [7]. Reasons for Performance Decline - Major reasons for the performance decline include significant credit impairment losses on accounts receivable and increased sales expenses due to the internationalization strategy [8]. - The company is actively pursuing legal measures to recover accounts receivable, with uncertain compensation amounts from the export credit insurance company [9]. Financial Data Disclaimer - The preliminary financial data provided is subject to change and will be finalized in the audited annual report [10].